1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lek Pharmaceuticals dd in Consumer Health (Slovenia)

Lek Pharmaceuticals dd in Consumer Health (Slovenia)

  • November 2015
  • -
  • Euromonitor International
  • -
  • 2 pages

Lek is a part of Sandoz, a global generics group. Lek is helping to build Sandoz’s reputation as a main provider of high-quality and affordable medicines. As a Sandoz company, Lek wishes to lead the generic pharmaceuticals industry and continuously set higher quality standards. It is committed to introducing innovative technologies and delivery methods to the generics market.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Lek Pharmaceuticals dd in Consumer Health (Slovenia)
LEK PHARMACEUTICALS DD IN CONSUMER HEALTH (SLOVENIA)
Euromonitor International
November 2015

LIST OF CONTENTS AND TABLES

Strategic Direction
Key Facts
Summary 1 Lek Pharmaceuticals dd: Key Facts
Summary 2 Lek Pharmaceuticals dd: Operational Indicators
Competitive Positioning
Summary 3 Lek Pharmaceuticals dd: Competitive Position 2015












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

North America Insulin Delivery Market Outlook to 2022

North America Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by Global Data

North America Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "North America Insulin Delivery Market Outlook to 2022", provides key market data on the North America Insulin Delivery ...

North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.